“…Taking into account the enormous potential of β-aryl enones or chalcones as privileged structures in the design and development of new therapeutic candidates, there remains an ever-expanding scope for the development of new methodologies to provide synthetic access to these building blocks. ,, We have recently reported synthetic methodologies to derive β-aryl/alkenyl enones or their saturated counterparts, β-aryl/alkenyl ethyl ketones (for example, chalcones and dihydrochalcones) from allyl alcohols and cyclopropanols as readily available starting materials by arylation and alkenylation with arylboronic and alkenylboronic acids (or esters), respectively, using modular Pd(II) catalytic systems. − The salient feature of these protocols was the exploitation of organoboronic acids or esters as powerful arylating or alkenylating agents that offer multiple advantages, including (a) commercial availability, (b) ease of synthesis, (c) relatively low toxicity, (d) high stability to air and moisture, and (e) facile tendency to undergo transmetallation with transition-metal complexes. , Importantly, the direct C–H borylation of arenes, heteroarenes, and alkenes under either transition-metal-catalyzed or metal-free conditions has significantly expanded the synthetic scope of organoboronic reagents. − …”